US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Actuate Therapeutics Inc

3.76

-0.3700-8.96%

Post-market: 3.760.00000.00%16:04 EST

Volume:30.63K

Turnover:117.69K

Market Cap:87.39M

PE:-3.12

High:4.22

Open:4.22

Low:3.72

Close:4.13

52wk High:11.99

52wk Low:3.72

Shares:23.24M

Float Shares:9.28M

Volume Ratio:0.98

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2044

EPS(LYR):-3.2588

ROE:-296.04%

ROA:-95.25%

PB:7.99

PE(LYR):-1.15

Loading ...

Overview Company News Filings

Actuate Therapeutics Inc - May Sell Common Stock up to $100 Mln - SEC Filing

THOMSON REUTERS

Actuate Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Craig-Hallum Reaffirms Their Buy Rating on Actuate Therapeutics, Inc. (ACTU)

Actuate Therapeutics Q3 EPS $(0.25) Beats $(0.28) Estimate

Actuate Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Actuate Therapeutics - Data to Support FDA and Ema Submissions Beginning Later This Year, Continuing Into Early 2026

THOMSON REUTERS

Actuate Therapeutics Inc - Recent Financing Extends Runway Through Key Regulatory Points

THOMSON REUTERS

Actuate Therapeutics Inc: Amended Elraglusib Ind Application With Updated Clinical Data From Phase 2 Trial for Metastatic Pancreatic Cancer

THOMSON REUTERS

Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months

Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

Actuate Therapeutics Shares Drop After Public Offering Prices

BRIEF-Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock

Actuate Therapeutics Plans Public Offering of Common Shares

MT Newswires Live

Actuate Therapeutics Announces Proposed Public Offering of Common Stock

BRIEF-Actuate Therapeutics Inc Files For Mixed Shelf Offering Of Up To $250 Million- SEC Filing

Actuate Therapeutics Inc Files for Mixed Shelf Offering of up to $250 Mln- SEC Filing

THOMSON REUTERS

B. Riley Initiates Actuate Therapeutics With Buy Rating, $20 Price Target

MT Newswires Live

U.S. RESEARCH ROUNDUP-CBRE Group, Horizon Bancorp, Ulta Beauty

Actuate Therapeutics Announces New Phase 1b Trial of Elra in Combination with Retifanlimab and mFOLFIRINOX for Advanced Pancreatic Cancer

Actuate Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACTU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ACTU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACTU\",,,,,undefined,":{"symbol":"ACTU","market":"US","secType":"STK","nameCN":"Actuate Therapeutics Inc","latestPrice":3.76,"timestamp":1771880400000,"preClose":4.13,"halted":0,"volume":30632,"hourTrading":{"tag":"盘后","latestPrice":3.76,"preClose":3.76,"latestTime":"16:04 EST","volume":2,"amount":7.52,"timestamp":1771880650080,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08958837772397098,"floatShares":9280300,"shares":23243328,"eps":-1.204351,"marketStatus":"Closed","change":-0.37,"latestTime":"02-23 16:00:00 EST","open":4.22,"high":4.22,"low":3.715,"amount":117694.5795,"amplitude":0.122276,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.204351,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771923600000},"marketStatusCode":5,"adr":0,"listingDate":1723521600000,"exchange":"NASDAQ","adjPreClose":4.13,"postHourTrading":{"tag":"盘后","latestPrice":3.76,"preClose":3.76,"latestTime":"16:04 EST","volume":2,"amount":7.52,"timestamp":1771880650080,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.984857},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACTU\",,,,,undefined,":{"symbol":"ACTU","floatShares":9280300,"roa":"-95.25%","roe":"-296.04%","lyrEps":-3.258828,"volumeRatio":0.984857,"shares":23243328,"dividePrice":0,"high":4.22,"amplitude":0.122276,"preClose":4.13,"low":3.715,"week52Low":3.715,"pbRate":"7.99","week52High":11.99,"institutionHeld":0,"latestPrice":3.76,"eps":-1.204351,"divideRate":0,"volume":30632,"delay":0,"ttmEps":-1.204351,"open":4.22,"prevYearClose":6.12,"prevWeekClose":4.13,"prevMonthClose":4.71,"prevQuarterClose":6.12,"fiveDayClose":4.33,"twentyDayClose":5.31,"sixtyDayClose":6.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACTU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"ACTU","fiscalQuarterEnding":"2025/09","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-08-14","symbol":"ACTU","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.3},{"market":"US","date":"2025-05-15","symbol":"ACTU","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACTU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACTU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1756270800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACTU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACTU","date":"2026-02-20","current":-3.122013,"percent":0.992248,"low":-9.225925,"twenty":-6.6744,"median":-5.836285,"eighty":-5.109147,"high":-3.930949,"avg":-5.898709,"sd":0.907564,"marketCap":98551710},"quantilePoints":[{"date":"2024-07-25","current":-6.211408,"twenty":-6.211408,"median":-6.211408,"eighty":-6.211408,"marketCap":172493433},{"date":"2024-08-09","current":-5.505609,"twenty":-6.211408,"median":-6.211408,"eighty":-6.070248,"marketCap":152893088},{"date":"2024-08-16","current":-5.987349,"twenty":-6.211408,"median":-6.167236,"eighty":-5.841451,"marketCap":166271233},{"date":"2024-08-23","current":-5.560665,"twenty":-6.211408,"median":-5.987349,"eighty":-5.556536,"marketCap":154422018},{"date":"2024-08-30","current":-5.540019,"twenty":-6.211408,"median":-5.870355,"eighty":-5.533137,"marketCap":153848669},{"date":"2024-09-06","current":-5.608839,"twenty":-6.158401,"median":-5.624324,"eighty":-5.529008,"marketCap":155759833},{"date":"2024-09-13","current":-5.512491,"twenty":-6.078798,"median":-5.608839,"eighty":-5.512491,"marketCap":153084204},{"date":"2024-09-20","current":-5.03075,"twenty":-6.012125,"median":-5.608839,"eighty":-5.509738,"marketCap":139706059},{"date":"2024-09-27","current":-4.249491,"twenty":-5.950186,"median":-5.560665,"eighty":-5.486339,"marketCap":122463357},{"date":"2024-10-04","current":-5.056014,"twenty":-5.921282,"median":-5.540019,"eighty":-5.041842,"marketCap":145706004},{"date":"2024-10-11","current":-4.981461,"twenty":-5.86072,"median":-5.519373,"eighty":-4.824223,"marketCap":143557524},{"date":"2024-10-18","current":-4.920464,"twenty":-5.785018,"median":-5.512491,"eighty":-4.844556,"marketCap":141799677},{"date":"2024-10-25","current":-5.774428,"twenty":-5.765917,"median":-5.512491,"eighty":-4.844556,"marketCap":166409538},{"date":"2024-11-01","current":-5.306781,"twenty":-5.809795,"median":-5.512491,"eighty":-4.893354,"marketCap":152932709},{"date":"2024-11-08","current":-5.937088,"twenty":-5.927371,"median":-5.540019,"eighty":-4.957062,"marketCap":171097131},{"date":"2024-11-15","current":-5.958745,"twenty":-5.939799,"median":-5.550342,"eighty":-5.011034,"marketCap":169534600},{"date":"2024-11-22","current":-6.164693,"twenty":-5.973458,"median":-5.595075,"eighty":-5.037775,"marketCap":175394091},{"date":"2024-11-29","current":-5.581175,"twenty":-6.024512,"median":-5.608839,"eighty":-5.04517,"marketCap":158792200},{"date":"2024-12-06","current":-6.144098,"twenty":-6.055165,"median":-5.638088,"eighty":-5.051947,"marketCap":174808142},{"date":"2024-12-13","current":-5.917556,"twenty":-6.037784,"median":-5.643249,"eighty":-5.107523,"marketCap":168362702},{"date":"2024-12-20","current":-4.647547,"twenty":-6.017783,"median":-5.638088,"eighty":-5.04517,"marketCap":132229175},{"date":"2024-12-27","current":-6.068584,"twenty":-6.019156,"median":-5.638088,"eighty":-5.043814,"marketCap":172659662},{"date":"2025-01-03","current":-5.718473,"twenty":-6.013664,"median":-5.622603,"eighty":-5.049236,"marketCap":162698527},{"date":"2025-01-10","current":-5.697878,"twenty":-5.992612,"median":-5.622603,"eighty":-5.054658,"marketCap":162112578},{"date":"2025-01-17","current":-5.917556,"twenty":-5.969958,"median":-5.636367,"eighty":-5.146627,"marketCap":168362702},{"date":"2025-01-24","current":-6.940428,"twenty":-6.032033,"median":-5.643249,"eighty":-5.178584,"marketCap":197464839},{"date":"2025-01-31","current":-6.199017,"twenty":-6.064465,"median":-5.677284,"eighty":-5.209185,"marketCap":176370673},{"date":"2025-02-07","current":-6.047989,"twenty":-6.091559,"median":-5.691423,"eighty":-5.241176,"marketCap":172073713},{"date":"2025-02-14","current":-5.327173,"twenty":-6.072917,"median":-5.687582,"eighty":-5.255778,"marketCap":151565495},{"date":"2025-02-21","current":-5.279119,"twenty":-6.065838,"median":-5.658037,"eighty":-5.254405,"marketCap":150198280},{"date":"2025-02-28","current":-4.970198,"twenty":-6.060665,"median":-5.639808,"eighty":-5.174772,"marketCap":141409044},{"date":"2025-03-07","current":-4.771115,"twenty":-6.057666,"median":-5.608839,"eighty":-5.040292,"marketCap":135744870},{"date":"2025-03-14","current":-5.189762,"twenty":-6.053039,"median":-5.581175,"eighty":-5.033989,"marketCap":141604361},{"date":"2025-03-21","current":-4.831847,"twenty":-6.048768,"median":-5.560665,"eighty":-5.014488,"marketCap":131838543},{"date":"2025-03-28","current":-5.655051,"twenty":-6.042497,"median":-5.560665,"eighty":-5.033989,"marketCap":154299924},{"date":"2025-04-04","current":-4.932064,"twenty":-6.028767,"median":-5.540019,"eighty":-4.987939,"marketCap":134572972},{"date":"2025-04-11","current":-5.483252,"twenty":-6.017783,"median":-5.519391,"eighty":-4.984609,"marketCap":149612331},{"date":"2025-04-17","current":-5.726634,"twenty":-6.012291,"median":-5.540019,"eighty":-4.990995,"marketCap":156253088},{"date":"2025-04-25","current":-6.406672,"twenty":-6.045243,"median":-5.553757,"eighty":-4.998855,"marketCap":174808142},{"date":"2025-05-02","current":-7.537682,"twenty":-6.061192,"median":-5.567445,"eighty":-5.009067,"marketCap":205668127},{"date":"2025-05-09","current":-7.408833,"twenty":-6.107591,"median":-5.601957,"eighty":-5.032369,"marketCap":202152432},{"date":"2025-05-16","current":-8.179286,"twenty":-6.139979,"median":-5.636367,"eighty":-5.039569,"marketCap":206987413},{"date":"2025-05-23","current":-7.830407,"twenty":-6.178422,"median":-5.644452,"eighty":-5.043814,"marketCap":198158566},{"date":"2025-05-30","current":-8.194792,"twenty":-6.211408,"median":-5.662735,"eighty":-5.049236,"marketCap":207379806},{"date":"2025-06-06","current":-7.047366,"twenty":-6.281396,"median":-5.690843,"eighty":-5.056014,"marketCap":178342709},{"date":"2025-06-13","current":-6.675228,"twenty":-6.406672,"median":-5.69465,"eighty":-5.089546,"marketCap":168925272},{"date":"2025-06-20","current":-5.806906,"twenty":-6.42894,"median":-5.722554,"eighty":-5.141086,"marketCap":146951253},{"date":"2025-06-27","current":-4.512175,"twenty":-6.410449,"median":-5.697878,"eighty":-5.08284,"marketCap":114186421},{"date":"2025-07-03","current":-5.109147,"twenty":-6.389172,"median":-5.691014,"eighty":-5.046525,"marketCap":129293559},{"date":"2025-07-11","current":-4.791279,"twenty":-6.365148,"median":-5.677284,"eighty":-5.035608,"marketCap":121249498},{"date":"2025-07-18","current":-4.853302,"twenty":-6.320988,"median":-5.645656,"eighty":-4.991444,"marketCap":122819071},{"date":"2025-07-25","current":-5.419262,"twenty":-6.287654,"median":-5.638088,"eighty":-4.976956,"marketCap":137141423},{"date":"2025-08-01","current":-5.620836,"twenty":-6.265937,"median":-5.628589,"eighty":-4.986182,"marketCap":142242535},{"date":"2025-08-08","current":-6.527901,"twenty":-6.287654,"median":-5.632466,"eighty":-4.991444,"marketCap":165196967},{"date":"2025-08-15","current":-6.908485,"twenty":-6.414227,"median":-5.639808,"eighty":-4.995735,"marketCap":170525437},{"date":"2025-08-22","current":-6.442036,"twenty":-6.458702,"median":-5.650353,"eighty":-5.00125,"marketCap":159011858},{"date":"2025-08-29","current":-6.908485,"twenty":-6.483225,"median":-5.670419,"eighty":-5.019908,"marketCap":170525437},{"date":"2025-09-05","current":-7.328709,"twenty":-6.512404,"median":-5.690843,"eighty":-5.033989,"marketCap":180898030},{"date":"2025-09-12","current":-5.859066,"twenty":-6.574176,"median":-5.69465,"eighty":-5.040292,"marketCap":144622132},{"date":"2025-09-19","current":-6.375067,"twenty":-6.549229,"median":-5.726634,"eighty":-5.04517,"marketCap":157358843},{"date":"2025-09-26","current":-6.175411,"twenty":-6.549229,"median":-5.729418,"eighty":-5.051947,"marketCap":152430635},{"date":"2025-10-03","current":-6.212557,"twenty":-6.533707,"median":-5.754096,"eighty":-5.069427,"marketCap":153347511},{"date":"2025-10-10","current":-7.512643,"twenty":-6.537578,"median":-5.770478,"eighty":-5.097386,"marketCap":185438171},{"date":"2025-10-17","current":-7.24334,"twenty":-6.589924,"median":-5.79172,"eighty":-5.109147,"marketCap":178790820},{"date":"2025-10-24","current":-6.732591,"twenty":-6.670885,"median":-5.814177,"eighty":-5.112248,"marketCap":166183775},{"date":"2025-10-31","current":-6.110407,"twenty":-6.6744,"median":-5.859066,"eighty":-5.12,"marketCap":150826102},{"date":"2025-11-07","current":-5.785385,"twenty":-6.670885,"median":-5.869501,"eighty":-5.13638,"marketCap":142803437},{"date":"2025-11-14","current":-5.536933,"twenty":-6.66337,"median":-5.85039,"eighty":-5.154603,"marketCap":136670768},{"date":"2025-11-21","current":-5.868654,"twenty":-6.637844,"median":-5.836285,"eighty":-5.160645,"marketCap":141551867},{"date":"2025-11-28","current":-7.352682,"twenty":-6.647528,"median":-5.86386,"eighty":-5.168486,"marketCap":177346592},{"date":"2025-12-05","current":-7.082858,"twenty":-6.676544,"median":-5.869501,"eighty":-5.172026,"marketCap":170838460},{"date":"2025-12-12","current":-7.150314,"twenty":-6.706669,"median":-5.884194,"eighty":-5.183365,"marketCap":172465493},{"date":"2025-12-19","current":-6.764853,"twenty":-6.718803,"median":-5.896423,"eighty":-5.185781,"marketCap":163168162},{"date":"2025-12-26","current":-6.321572,"twenty":-6.721745,"median":-5.917556,"eighty":-5.189762,"marketCap":152476231},{"date":"2026-01-02","current":-5.897564,"twenty":-6.709975,"median":-5.917556,"eighty":-5.218313,"marketCap":142249167},{"date":"2026-01-09","current":-6.051748,"twenty":-6.706828,"median":-5.918043,"eighty":-5.231645,"marketCap":145968099},{"date":"2026-01-16","current":-5.12664,"twenty":-6.706347,"median":-5.916837,"eighty":-5.218313,"marketCap":123654504},{"date":"2026-01-23","current":-5.251915,"twenty":-6.701519,"median":-5.896423,"eighty":-5.230096,"marketCap":126676137},{"date":"2026-01-30","current":-4.567721,"twenty":-6.691045,"median":-5.884194,"eighty":-5.187481,"marketCap":110173374},{"date":"2026-02-06","current":-4.162986,"twenty":-6.680588,"median":-5.869501,"eighty":-5.163192,"marketCap":100411176},{"date":"2026-02-13","current":-4.085894,"twenty":-6.675886,"median":-5.86386,"eighty":-5.121593,"marketCap":98551710},{"date":"2026-02-20","current":-4.085894,"twenty":-6.6744,"median":-5.836285,"eighty":-5.109147,"marketCap":98551710}],"updateTime":1771909080579},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACTU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2587758893","title":"Actuate Therapeutics Inc - May Sell Common Stock up to $100 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2587758893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587758893?lang=en_us&edition=fundamental","pubTime":"2025-11-29 06:23","pubTimestamp":1764368587,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nFWN3X40LI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"2584943964","title":"Actuate Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584943964","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584943964?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:42","pubTimestamp":1763552520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACTU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 19, 2025 06:42 ET (11:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU"],"gpt_icon":0},{"id":"2583507537","title":"Craig-Hallum Reaffirms Their Buy Rating on Actuate Therapeutics, Inc. (ACTU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583507537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583507537?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:45","pubTimestamp":1763131515,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Albert Lowe maintained a Buy rating on Actuate Therapeutics, Inc. today and set a price target of $25.00. Lowe covers the Heal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-reaffirms-their-buy-rating-on-actuate-therapeutics-inc-actu-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-reaffirms-their-buy-rating-on-actuate-therapeutics-inc-actu-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACTU"],"gpt_icon":0},{"id":"2583548422","title":"Actuate Therapeutics Q3 EPS $(0.25) Beats $(0.28) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583548422","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583548422?lang=en_us&edition=fundamental","pubTime":"2025-11-14 06:44","pubTimestamp":1763073896,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics (NASDAQ:ACTU) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.28) by 10.07 percent. This is a 54.55 percent increase over losses of $(0.55) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48853453/actuate-therapeutics-q3-eps-0-25-beats-0-28-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Actuate Therapeutics Q3 EPS $(0.25) Beats $(0.28) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU"],"gpt_icon":0},{"id":"2569879172","title":"Actuate Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2569879172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569879172?lang=en_us&edition=fundamental","pubTime":"2025-09-23 18:50","pubTimestamp":1758624600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACTU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 23, 2025 06:50 ET (10:50 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU"],"gpt_icon":0},{"id":"2569822827","title":"Actuate Therapeutics - Data to Support FDA and Ema Submissions Beginning Later This Year, Continuing Into Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2569822827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569822827?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:45","pubTimestamp":1758545100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nTUA95ZVFJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACTU"],"gpt_icon":0},{"id":"2569822387","title":"Actuate Therapeutics Inc - Recent Financing Extends Runway Through Key Regulatory Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2569822387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569822387?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:45","pubTimestamp":1758545100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nTUA95ZVFJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"2569782284","title":"Actuate Therapeutics Inc: Amended Elraglusib Ind Application With Updated Clinical Data From Phase 2 Trial for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2569782284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569782284?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:45","pubTimestamp":1758545100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nTUA95ZVFJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACTU"],"gpt_icon":0},{"id":"2569780991","title":"Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2569780991","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569780991?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:45","pubTimestamp":1758545100,"startTime":"0","endTime":"0","summary":"Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of care and novel immunotherapiesRecent financing provides exte","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/22/3153932/0/en/Actuate-Therapeutics-Provides-FDA-with-Updated-Clinical-Data-Package-to-Support-Planned-Regulatory-Interactions-with-FDA-and-EMA-Over-the-Coming-Months.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4139","EMA","ACTU"],"gpt_icon":0},{"id":"2566119399","title":"Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2566119399","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566119399?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:01","pubTimestamp":1757620860,"startTime":"0","endTime":"0","summary":"CHICAGO and FORT WORTH, Texas, Sept.  11, 2025  (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on develo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/11/3148863/0/en/Actuate-Therapeutics-Announces-Closing-of-17-25-Million-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Over-Allotment-Option.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","ACTU","BK4539","BK4139"],"gpt_icon":0},{"id":"2566602548","title":"Actuate Therapeutics Shares Drop After Public Offering Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2566602548","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566602548?lang=en_us&edition=fundamental","pubTime":"2025-09-10 21:50","pubTimestamp":1757512200,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics shares were 23% lower, at $6.56, after the company said it has priced an underwritten public offering of 2.1 million shares at $7 a share.The biopharmaceutical company said it has granted the underwriters a 30-day option to buy up to 321,000 additional shares at the public offering price per share, less underwriting discounts and commissions.The company intends to use the proceeds from the proposed offering for working capital and general corporate purposes.The offering is expected to close Thursday, subject to the satisfaction of customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2566609990","title":"BRIEF-Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2566609990","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566609990?lang=en_us&edition=fundamental","pubTime":"2025-09-10 20:43","pubTimestamp":1757508221,"startTime":"0","endTime":"0","summary":"BRIEF-Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common StockSept 10 (Reuters) - Actuate Therapeutics Inc ACTU.O:ACTUATE THERAPEUTICS ANNOUNCES PRICING OF $15.0 MILLION","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA8BBDFX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"gpt_icon":0},{"id":"2566465086","title":"Actuate Therapeutics Plans Public Offering of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2566465086","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566465086?lang=en_us&edition=fundamental","pubTime":"2025-09-10 05:39","pubTimestamp":1757453959,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics  said late Tuesday it plans a public offering of common shares.The company intends to grant underwriters a 30-day overallotment option to buy up to an additional 15% of the shares.The company said it plans to use net proceeds for general corporate purposes.Shares of Actuate Therapeutics were down more than 16% in after-hours trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","BK4007","ACTU","BK4539"],"gpt_icon":0},{"id":"2566051648","title":"Actuate Therapeutics Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2566051648","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566051648?lang=en_us&edition=fundamental","pubTime":"2025-09-10 04:07","pubTimestamp":1757448420,"startTime":"0","endTime":"0","summary":"CHICAGO and FORT WORTH, Texas, Sept.  09, 2025  (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on develo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/09/3147344/0/en/Actuate-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ACTU","LENZ","BK4539"],"gpt_icon":0},{"id":"2564335752","title":"BRIEF-Actuate Therapeutics Inc Files For Mixed Shelf Offering Of Up To $250 Million- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2564335752","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564335752?lang=en_us&edition=fundamental","pubTime":"2025-09-03 05:47","pubTimestamp":1756849674,"startTime":"0","endTime":"0","summary":"BRIEF-Actuate Therapeutics Inc Files For Mixed Shelf Offering Of Up To $250 Million- SEC FilingActuate Therapeutics Inc ACTU.O:ACTUATE THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING OF UP TO $250 MILLION- SEC FILINGSource text: [ID:n0001683168-25-006622]Further company coverage: ACTU.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nFWN3UP0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"2564195338","title":"Actuate Therapeutics Inc Files for Mixed Shelf Offering of up to $250 Mln- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2564195338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564195338?lang=en_us&edition=fundamental","pubTime":"2025-09-03 04:30","pubTimestamp":1756845010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nFWN3UP0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"2562738376","title":"B. Riley Initiates Actuate Therapeutics With Buy Rating, $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2562738376","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562738376?lang=en_us&edition=fundamental","pubTime":"2025-08-26 19:11","pubTimestamp":1756206719,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics (ACTU) has an average rating of Buy and mean price target of $26.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","ACTU","RILY"],"gpt_icon":0},{"id":"2562070222","title":"U.S. RESEARCH ROUNDUP-CBRE Group, Horizon Bancorp, Ulta Beauty","url":"https://stock-news.laohu8.com/highlight/detail?id=2562070222","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562070222?lang=en_us&edition=fundamental","pubTime":"2025-08-26 14:52","pubTimestamp":1756191141,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CBRE Group, Horizon Bancorp, Ulta BeautyAug 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CBR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nL4N3UI0GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1543694498.USD","LU0980610538.SGD","LU1169589451.USD","POST","SMTC","LU1992135399.USD","ACTU","LU1620156130.USD","LU0154245756.USD","BK4212","LU1596574779.USD","BK4023","BK4161","MDGL","LU2106854487.HKD","LU2125910336.SGD","CBRE","LU0154245673.USD","HBNC","SG9999004253.SGD","BK4588","LU0130102774.USD","LU1923621640.USD","LU0054578231.USD","LU1620156213.USD","LU2041044095.USD","LU2229751404.USD","LU1721427968.SGD","LU1917777945.USD","LU2360108059.USD","BK4200","BK4157","LU1165135440.EUR","ULTA","XYL","LU2125910179.SGD","LU2298321311.HKD","FSK","NSSC","BK4548","LU0266013472.USD","JLL","BK4585","LU0320765489.SGD","SG9999001077.SGD","BK4139","VRNT","LU1892829315.USD","LU1169590202.USD","LU2308191902.HKD"],"gpt_icon":0},{"id":"2562824030","title":"Actuate Therapeutics Announces New Phase 1b Trial of Elra in Combination with Retifanlimab and mFOLFIRINOX for Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2562824030","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562824030?lang=en_us&edition=fundamental","pubTime":"2025-08-25 22:01","pubTimestamp":1756130472,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics Announces New Phase 1b Trial of Elra in Combination with Retifanlimab and mFOLFIRINOX for Advanced Pancreatic Cancer. Actuate Therapeutics Inc. has announced plans for a Phase 1b clinical trial to evaluate the combination of their drug elra with Incyte Corporation's PD-1 inhibitor retifanlimab and modified FOLFIRINOX  as frontline therapy for advanced pancreatic adenocarcinoma. This study will be conducted in collaboration with UPMC Hillman Cancer Center and Incyte. The trial aims to explore synergistic opportunities for patients who have not yet received systemic therapy and to assess ways to optimize elraglusib's potential through a complementary multi-agent approach. Results from this trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL1s25yf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","BK4550","BK4585","BK4588","BK4532","ACTU","BK4139"],"gpt_icon":0},{"id":"2560099329","title":"Actuate Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2560099329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560099329?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:41","pubTimestamp":1755513660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACTU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 18, 2025 06:41 ET (10:41 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}